Dr. Reddy dips 5 per cent
Dr. Reddy dips 5 per cent

Dr. Reddy dips 5 per cent

Gayathri Udyawar Article rating: 5.0

Leading pharmaceutical major lost more than 5 per cent in early trade on Wednesday following reports that USFDA has issued a Complete Response Letter with regards to the generic Nuvaring.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 2.5

Overall volumes in futures & options currently stand at 2,08,59,867 contracts with a turnover of Rs.13,64,009.54 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: 2.5

Overall volumes in futures & options currently stand at 2,08,59,867 contracts with a turnover of Rs.13,64,009.54 crore.

Index trend and stocks in action August 14, 2019
Index trend and stocks in action August 14, 2019

Index trend and stocks in action August 14, 2019

Karan Dsij Article rating: 5.0

Nifty needs to sustain above its crucial 10,800 mark to keep the pullback option open. On the upside, the level of 10,980-11,040 is likely to act as immediate resistance. Stocks in news: Infosys, TCS, Anuh Pharma, Concor.

Quarterly results to watch out on August 14
Quarterly results to watch out on August 14

Quarterly results to watch out on August 14

Shohini Nath Article rating: 3.7

The following stocks would be in focus during Wednesday’s trading session in light of their results announcement: Ahluwalia Contracts, Deepak Fertilisers, Edelweiss Financial Services, Everready Industries and GMM Pfaudler.

Sensex tanks 624 points even as RIL gains 10 pc
Sensex tanks 624 points even as RIL gains 10 pc

Sensex tanks 624 points even as RIL gains 10 pc

Gayathri Udyawar Article rating: 5.0

Despite a spectacular run-up by Reliance, the benchmark index BSE Sensex closed down at 36,958.16, down by 623.75 points or 1.66 per cent on Tuesday. The Nifty50 closed at 10,925.85, down by 183.80 points or 1.65 per cent.


Unichem Laboratories receives ANDA approval
Unichem Laboratories receives ANDA approval

Unichem Laboratories receives ANDA approval

Amir Shaikh Article rating: 5.0

Unichem Laboratories on Tuesday informed the bourses that it has received ANDA approval from the United States Food and Drug Administration (USFDA) for Unichem's Tramadol Hydrochloride Tablets.

RSS
First30853086308730883090309230933094Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR